BioSpace News Archive

New programs added in respiratory and cardio-metabolic diseases

Perrigo Company plc (NYSE; TASE: PRGO) announced today that Promius Pharma, LLC initiated patent litigation on May 22, 2018.

Lawrence Toll, Ph.D., expected to describe company’s novel opioid that shows no signs of addiction potential

Traver Hutchins and H. Scott Nesbitt Being Honored for Exceptional Leadership in Strategy, Data Analytics

Biotechnology leader NanoSphere Health Sciences, LLC (CSE: NSHS) (OTC: NSHSF) has retained the services of Gravitas Securities Inc. (“Gravitas”) to act as financial advisors to the company. NanoSphere also wishes to announce that it has granted 3,165,555 options to directors, officers and consultants of the company at a price of $0.65.

Approach may offer value to health systems and clinicians in targeting interventions to prevent suicide

Curis, Inc. today announced that Robert Martell, M.D., Ph.D., has been appointed Head of Research and Development.

Lupin Confirms Validity of OMIDRIA Patents

Company’s abrasion tip support catheter demonstrated safe and effective

This clearance step is a key quality assurance milestone under Stellar’s initiatives to increase the scalability and throughput capacity of its manufacturing processes.